Menu

NIIMBL

ABOUT NIIMBL

NIIMBL, established under the University of Delaware by the Department of Commerce, focuses on enabling more efficient and flexible manufacturing capabilities for existing and emerging biopharmaceutical products, and developing a world-leading biopharmaceutical manufacturing workforce and their roadmap for biomanufacturing.

Their roadmap for the manufacturing needs and propose a vision of the future for three key topics areas:

  • (1) Vaccines
  • (2) Antibody-Drug Conjugates (ADC) and Bi-specific Antibodies
  • (3) Gene Therapies

For more information on membership, please visit here

 

Staying Current with NIMBL:

July 3rd - NIIMBL currently has 54 differing projects with call for proposals open. Find out about three currently highlighted by NIMBL as well as a link to view all of the current project opportunities: 

  1. Adaptive Process Control and Advanced Sensing for Robust mAb Glycan Quality. 

  1. Single-use Center of Excellence Based on a Simulated-GMP Process for mAb Production. 

  1. SPIDER Network for Automation Training.